Bills/Member
R

McCaul, Michael T. [R-TX-10]

Republican · TX · 3 bills sponsored

H.R. 7506House
Feb 11, 2026

Decreasing Russian Oil Profits Act of 2026

In CommitteeForeign Affairs
McCaul, Michael T. [R-TX-10] (R-TX)· 5 cosponsors

# Decreasing Russian Oil Profits Act of 2026 - Summary **What the Bill Would Do** HR 7506 aims to reduce profits that Russia earns from selling oil. While the bill's specific provisions aren't detailed in the available information, legislation with this title typically seeks to limit Russia's energy revenue through measures like sanctions, price caps, or restrictions on oil purchases and sales. These tools are generally used to pressure Russia economically, particularly in response to its foreign policy actions. **Who It Affects** This bill would primarily impact Russia's economy and energy sector. It could also affect American consumers and businesses involved in energy markets, as restrictions on Russian oil can influence global oil prices and energy costs. International allies and trading partners could be affected depending on the bill's specific measures. **Current Status** The bill is currently in committee, meaning it has been introduced but has not yet been debated or voted on by the full House of Representatives. This early stage suggests the legislation is still being reviewed and developed. The bill is sponsored by Representative Michael McCaul, a Republican from Texas. *Note: Detailed provisions cannot be summarized without access to the full legislative text.*

Latest: Feb 11, 2026Read more →
H.R. 1262House
Feb 12, 2025

Mikaela Naylon Give Kids a Chance Act

Passed HouseHealthcare
McCaul, Michael T. [R-TX-10] (R-TX)· 313 cosponsors

# Mikaela Naylon Give Kids a Chance Act (HR 1262) – Summary **What It Does:** This bill expands the FDA's power to support and enforce research on rare diseases affecting children. It allows pharmaceutical companies to test new cancer drugs in combination with already-approved medications, gives the FDA authority to punish companies that don't complete required pediatric studies, and extends a "priority review voucher" program through 2029. These vouchers reward drug developers who research treatments for rare pediatric diseases by allowing them to fast-track approval of other drugs. The bill also reauthorizes pediatric research programs through 2027. **Who It Affects:** Children with rare diseases—particularly cancer—are the primary beneficiaries, as the bill aims to encourage more research into treatments. Pharmaceutical companies are also significantly affected since they face stricter requirements to study drugs in pediatric patients and potential penalties for non-compliance. The FDA gains new enforcement tools to ensure companies follow through on pediatric research commitments. **Current Status:** The bill has already passed the House of Representatives and is moving through the legislative process.

Latest: Dec 2, 2025Read more →
H.R. 625House
Jan 22, 2025

LACA

In CommitteeJudiciary
McCaul, Michael T. [R-TX-10] (R-TX)· 1 cosponsor

# Local Access to Courts Act (HR 625) Summary **What the Bill Does** The Local Access to Courts Act would require federal courts to hold sessions in two additional cities: College Station, Texas (in the Galveston Division of the Southern District of Texas) and El Centro, California (in the Southern District of California). Currently, these locations are not designated court session sites, meaning residents must travel to other cities to access federal court. **Who It Affects** This bill primarily affects residents and businesses in College Station, Texas and El Centro, California who need to use federal courts. By adding these locations as official court session sites, the bill aims to reduce travel burdens for litigants, attorneys, and court users in these areas. **Current Status** The bill was introduced by Rep. Michael T. McCaul (R-TX) and is currently in committee, meaning it has not yet been debated or voted on by the full House of Representatives. No action has been taken since its introduction.

Latest: Jan 22, 2025Read more →